Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.

Radboud University Medical Center

Status: Unknown

Conditions: Head and Neck Cancer

Treatments: Other: CT-FDG/PET scan of the head-and-neck region

Study type: Observational

Funder types: Other

Identifiers

NCT00782691

2008/060

Details and patient eligibility

About

Various methods of FDG-PET signal segmentation will be validated by correlation of histopathologically measured tumor dimensions in lymph node dissection specimens of head-and-neck cancer patients.

Enrollment: 15 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients with N+ squamous cell carcinoma of the head and neck, planned for neck dissection.
• Age >18 years.

Exclusion criteria

• Pregnancy.
• Women breast feeding

Trial design

15 participants in 1 patient group

Head-and-neck cancer patients.

Description:

Head-and-neck cancer patients eligible for therapeutic lymph node dissection of cervical nodes.

Treatment:

Other: CT-FDG/PET scan of the head-and-neck region